![]() |
市場調查報告書
商品編碼
2148946
壓迫療法市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。Compression Therapy Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球壓迫療法市場預計2025年達到45.8億美元,2026年達到48.9億美元,到2034年達到81.5億美元。推動該市場成長的因素包括靜脈和淋巴系統疾病盛行率的上升、老年人口的成長、人們對壓迫療法的認知不斷提高以及產品的持續創新。北美地區預計將在2025年佔壓迫療法市場34.77%的佔有率,這得益於其先進的醫療基礎設施、高額的醫療支出、積極的研究活動以及淋巴水腫和下肢靜脈潰瘍患病率的上升。
市場定義和範圍
壓迫療法是一種臨床認可的治療方法,透過對肢體施加可控壓力來改善靜脈血液循環並促進淋巴引流。它廣泛用於治療淋巴水腫、下肢靜脈潰瘍、深層靜脈栓塞症、慢性靜脈功能不全和其他血管疾病。相關產品包括壓力服、壓力幫浦和其他專用系統。醫院、診所、療養院和居家照護機構對壓力療法的日益普及正在推動市場成長。此外,科技的進步也正在創造更舒適、更有效、更人性化的壓迫療法解決方案。
市場動態
成長要素-靜脈和淋巴系統疾病盛行率增加
淋巴水腫、下肢靜脈潰瘍、靜脈曲張和深層靜脈栓塞症的發生率不斷上升,是推動市場成長的主要因素。缺乏運動、肥胖、懷孕、血栓症病史、手術和慢性靜脈功能不全都會增加這些疾病的風險。人們對壓力衣和氣動加壓裝置的認知不斷提高,促使醫護人員和患者採用這些療法。
趨勢-先進壓縮服的普及率不斷提高
壓力衣作為一種有效的慢性靜脈和淋巴疾病治療方法,其應用日益廣泛。製造商不斷推出先進的壓力衣和多成分壓力系統,旨在改善壓力分佈、提升舒適度和治療效果。產品研發和臨床研究的不斷活性化也進一步推動了壓力衣的普及。
阻礙因素-高成本和認知度低
開發中國家對壓迫療法的認知度高成本昂貴,仍是嚴峻的挑戰。由於經濟原因、醫療基礎設施不足以及對現有治療方案缺乏了解,新興市場的患者和醫護人員可能難以獲得先進的產品。
新冠疫情的影響
新冠疫情擾亂了醫療服務、選擇性治療、產品生產和分銷網路。醫院就診量減少和非緊急手術的延遲影響了某些壓迫療法產品的需求。然而,對居家醫療和遠距醫療的日益重視為自助式產品創造了新的機會。醫療專業人員也更加重視能夠減少不必要住院治療的方案,這推動了人們對居家照護壓迫療法解決方案的長期需求。
副產品
市場區隔包括壓力衣、壓力幫浦和其他產品。壓力衣憑藉其在靜脈和淋巴疾病治療中的廣泛應用,佔市場主導地位,預計到2025年將佔市場佔有率的71.8%。壓力泵預計將實現強勁成長,這得益於其在淋巴水腫治療中日益普及以及新產品的不斷推出。
用途別
應用範圍包括下肢靜脈潰瘍、深層靜脈栓塞症(DVT)、淋巴水腫等。由於患者人數不斷增加以及壓力幫浦和壓力衣的使用日益普及,淋巴水腫已成為一個主要的應用領域。下肢靜脈潰瘍也對市場貢獻顯著,因為這種疾病在老年患者和慢性靜脈疾病患者中較為常見。
最終用戶
市場涵蓋醫院和診所、療養院以及居家照護。由於擁有技術精湛的醫護人員、先進的治療設施、充足的產品供應以及優惠的保險報銷條款,醫院和診所預計將繼續保持其領先地位。隨著老年人口的成長以及患者對更便利治療方案需求的增加,居家照護正蓬勃發展。
北美洲
北美是市場的主要驅動力,本報告的區域分析顯示,該地區市場規模達10.5億美元。大量的研發投入、新產品的推出、完善的醫療保健基礎設施以及淋巴水腫和靜脈疾病的高發生率,都支撐了該地區的需求。
歐洲
預計歐洲將繼續保持其作為關鍵市場的地位,這得益於新產品的推出、完善的醫療保健體係以及人們對壓迫療法的日益了解。對先進解決方案不斷成長的需求正促使製造商加強其在歐洲各國的業務佈局。
亞太地區
亞太地區預計將成為成長最快的地區,其成長主要受老年人口成長、可支配收入增加、醫療基礎設施改善以及慢性靜脈和淋巴疾病患者人數增加等因素驅動。在日本,預計到2025年,該市場規模將達到2.46億美元。
拉丁美洲、中東和非洲
在拉丁美洲、中東和非洲,由於醫療基礎設施的改善和先進壓縮產品的可近性提高,預計市場將逐步擴張。不斷成長的未滿足醫療需求和日益增強的意識正在全部區域的商業機會提供支持。
The global compression therapy market size was valued at USD 4.58 billion in 2025 and is projected to reach USD 4.89 billion in 2026 and USD 8.15 billion by 2034. The market is supported by the increasing prevalence of venous and lymphatic disorders, a growing geriatric population, rising awareness of compression-based treatment, and continuous product innovation. North America dominated the compression therapy market with a 34.77% share in 2025, supported by advanced healthcare infrastructure, high healthcare expenditure, strong research activities, and increasing prevalence of lymphedema and venous leg ulcers.
Market Definition and Scope
Compression therapy is a clinically established treatment approach that applies controlled pressure to the limbs to improve venous blood circulation and support lymphatic drainage. It is widely used for managing lymphedema, venous leg ulcers, deep vein thrombosis, chronic venous insufficiency, and other vascular conditions. Products include compression garments, compression pumps, and other specialized systems. Growing adoption across hospitals, clinics, nursing care centers, and home-care settings is expanding the market. Technological improvements are also creating more comfortable, effective, and patient-friendly compression solutions.
Market Dynamics
Drivers - Increasing Prevalence of Venous and Lymphatic Disorders
The rising incidence of lymphedema, venous leg ulcers, varicose veins, and deep vein thrombosis is a major factor supporting market growth. Immobility, obesity, pregnancy, previous thrombosis, surgeries, and chronic venous insufficiency can increase the risk of these conditions. Growing awareness of compression garments and pneumatic compression devices is encouraging healthcare professionals and patients to adopt these treatment options.
Trends - Growing Adoption of Advanced Compression Garments
Compression garments are increasingly being used as an effective option for managing chronic venous and lymphatic disorders. Manufacturers are introducing advanced garments and multi-component compression systems designed to improve pressure distribution, comfort, and treatment effectiveness. Increasing product development and clinical research are further supporting adoption.
Restraints - High Cost and Limited Awareness
The high cost of compression pumps and limited awareness of compression therapy in developing countries remain important challenges. Patients and healthcare providers in emerging markets may have restricted access to advanced products because of affordability, inadequate healthcare infrastructure, and limited knowledge about available treatment options.
Impact of COVID-19
The COVID-19 pandemic disrupted healthcare services, elective treatments, product manufacturing, and distribution networks. Reduced hospital visits and delays in non-emergency procedures affected demand for certain compression therapy products. However, the increased focus on home-based healthcare and remote patient management created opportunities for products suitable for independent use. Healthcare providers also placed greater emphasis on treatment approaches that could reduce unnecessary hospital visits, supporting long-term interest in home-care compression solutions.
By Product
The market is segmented into compression garments, compression pumps, and others. Compression garments dominated the market and accounted for 71.8% of the market in 2025, supported by their broad use in venous and lymphatic disease management. Compression pumps are expected to experience strong growth due to increasing adoption for lymphedema treatment and continued product launches.
By Application
Applications include venous leg ulcer, DVT, lymphedema, and others. Lymphedema represents a major application area because of the increasing patient population and growing use of compression pumps and garments. Venous leg ulcers also contribute significantly due to their prevalence among elderly patients and individuals with chronic venous conditions.
By End User
The market includes hospitals & clinics, nursing care centers, home care, and others. Hospitals & clinics are expected to maintain a leading position because of skilled healthcare professionals, advanced treatment facilities, product availability, and favorable reimbursement conditions. Home care is gaining momentum as the geriatric population increases and patients seek convenient treatment options.
North America
North America led the market, with a regional market value of USD 1.05 billion in the reported regional analysis. High R&D investment, product launches, developed healthcare infrastructure, and the prevalence of lymphedema and venous diseases support regional demand.
Europe
Europe is expected to maintain its position as a significant market, supported by new product launches, established healthcare systems, and increasing awareness of compression-based treatment. Growing demand for advanced solutions is encouraging manufacturers to strengthen their presence across European countries.
Asia Pacific
Asia Pacific is projected to register the fastest growth, supported by an expanding geriatric population, increasing disposable income, improving healthcare infrastructure, and a growing patient pool suffering from chronic venous and lymphatic disorders. Japan is expected to reach USD 246.0 million by 2025.
Latin America and Middle East & Africa
Latin America and the Middle East & Africa are expected to experience moderate expansion as healthcare infrastructure improves and advanced compression products become more accessible. Increasing unmet medical needs and growing awareness are supporting opportunities across these regions.
Competitive Landscape
Key companies operating in the compression therapy market include SIGVARIS, 3M, Arjo, PAUL HARTMANN Pty. Ltd., medi GmbH & Co. KG, Essity Aktiebolag, Smith & Nephew, Bio Compression Systems, Inc., and Tactile Systems Technology, Inc. Companies are focusing on new product development, distribution expansion, strategic partnerships, acquisitions, and portfolio diversification to strengthen their market positions.
Key Industry Developments
Koya Medical received FDA clearance for its compression therapy system designed for the lower extremities. DeRoyal entered a USD 1.2 million agreement with Tyndall and RCSI SWaT researchers to advance compression wound therapy. AIROS Medical introduced updated compression therapy products, including the AIROS 6 Sequential Compression Therapy device and Arm Plus garments. Theragun acquired RP Sports and its RecoveryPump clinical pneumatic compression technology product line.
Report Coverage
The compression therapy market report provides qualitative and quantitative insights into market size, market value, segmentation, regional analysis, competitive dynamics, product developments, and emerging opportunities. It evaluates compression garments, compression pumps, applications, and end-user categories while examining regional market conditions and major industry developments. The report also covers product innovation, strategic partnerships, mergers and acquisitions, regulatory developments, healthcare infrastructure, and changing treatment preferences.
Conclusion
The compression therapy market is positioned for continued growth as the prevalence of venous and lymphatic disorders increases and healthcare providers adopt advanced compression-based treatment solutions. The global market is projected to increase from USD 4.58 billion in 2025 to USD 4.89 billion in 2026 and USD 8.15 billion by 2034. Compression garments will remain a key product category, while compression pumps and home-care solutions are expected to create additional opportunities. Rising geriatric populations, improved healthcare infrastructure, product innovation, and greater awareness of effective vascular and lymphatic disease management will remain important factors shaping the market.
Unit Value (USD billion)
Segmentation By Product
By Application
By End User
By Geography